Rokote Laboratories Finland Oy

This is an early-stage study testing a new COVID-19 vaccine given as a nasal spray. Researchers want to see if two slightly different versions of the vaccine are safe and can trigger a good immune response in healthy adults. Participants will get two doses, one month apart, and t…